{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:58:15Z","timestamp":1763535495885},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T00:00:00Z","timestamp":1510099200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00059-017-4641-7","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T13:11:35Z","timestamp":1510146695000},"page":"728-738","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Akuter Myokardinfarkt bei Patienten mit ST-Strecken-Hebungs-Infarkt"],"prefix":"10.1007","volume":"42","author":[{"given":"H.","family":"Thiele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Desch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"de Waha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"4641_CR1","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS et\u00a0al (2012) Third universal definition of myocardial infarction. Eur Heart\u00a0J 33:2551\u20132567","journal-title":"Eur Heart J"},{"key":"4641_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjmed.2010.07.023","volume":"124","author":"DD Mcmanus","year":"2011","unstructured":"Mcmanus DD, Gore J, Yarzebski J et\u00a0al (2011) Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med 124:40\u201347","journal-title":"Am J Med"},{"key":"4641_CR3","volume-title":"Swedeheart annual report 2015","author":"T Jernberg","year":"2016","unstructured":"Jernberg T (2016) Swedeheart annual report 2015. Karolinska University Hospital, Stockholm"},{"key":"4641_CR4","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/eurheartj\/eht529","volume":"35","author":"SD Kristensen","year":"2014","unstructured":"Kristensen SD, Laut KG, Fajadet J et\u00a0al (2014) Reperfusion therapy for ST elevation acute myocardial infarction 2010\/2011: current status in 37 ESC countries. Eur Heart\u00a0J 35:1957\u20131970","journal-title":"Eur Heart J"},{"key":"4641_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/2012.jama.11348","volume":"308","author":"E Puymirat","year":"2012","unstructured":"Puymirat E, Simon T, Steeg PG et al (2012) Association of changes in clinical characteristics and management with improvement in survival among patients with st-elevation myocardial infarction. JAMA 308:998. \n                        https:\/\/doi.org\/10.1001\/2012.jama.11348","journal-title":"JAMA"},{"key":"4641_CR6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/heartjnl-2013-304517","volume":"100","author":"CP Gale","year":"2014","unstructured":"Gale CP, Allan V, Cattle BA et\u00a0al (2014) Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003\u20132010: a\u00a0multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). Heart 100:582\u2013589","journal-title":"Heart"},{"key":"4641_CR7","doi-asserted-by":"publisher","DOI":"10.10931\/393","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, James S, Agewall S et al (2017) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart\u00a0J. \n                        https:\/\/doi.org\/10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"key":"4641_CR8","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.114.014494","volume":"131","author":"D Stub","year":"2015","unstructured":"Stub D, Smith K, Bernard S et al (2015) Air versus oxygen in ST-segment-elevation myocardial infarction. Circulation 131:2143\u20132150","journal-title":"Circulation"},{"key":"4641_CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ahj.2013.09.022","volume":"167","author":"R Hofmann","year":"2014","unstructured":"Hofmann R, James SK, Svensson L et\u00a0al (2014) DEtermination of the role of OXygen in suspected acute myocardial infarction trial. Am Heart\u00a0J 167:322\u2013328","journal-title":"Am Heart J"},{"key":"4641_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/eurheartj\/ehv547","volume":"37","author":"J Kubica","year":"2016","unstructured":"Kubica J, Adamski P, Ostrowska M et al (2016) Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. Eur Heart\u00a0J 37:245\u2013252","journal-title":"Eur Heart J"},{"key":"4641_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijcard.2016.04.077","volume":"215","author":"J Kubica","year":"2016","unstructured":"Kubica J, Kubica A, Jilma B et\u00a0al (2016) Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors. Int J Cardiol 215:201\u2013208","journal-title":"Int J Cardiol"},{"key":"4641_CR12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","volume":"377","author":"SS Jolly","year":"2011","unstructured":"Jolly SS, Yusuf S, Cairns J et\u00a0al (2011) Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a\u00a0randomised, parallel group, multicentre trial. Lancet 377:1409\u20131420","journal-title":"Lancet"},{"key":"4641_CR13","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.jacc.2014.05.075","volume":"64","author":"MA Mamas","year":"2014","unstructured":"Mamas MA, Anderson SG, Carr M et\u00a0al (2014) Baseline bleeding risk and arterial access\u00a0site practice in relation to procedural outcomes after percutaneous\u00a0coronary intervention. J\u00a0Am Coll Cardiol 64:1554\u20131564","journal-title":"J. Am. Coll. Cardiol."},{"key":"4641_CR14","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2012.06.017","volume":"60","author":"E Romagnoli","year":"2012","unstructured":"Romagnoli E, Biondi-Zoccai G, Sciahbasi A et al (2012) Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study. J\u00a0Am Coll Cardiol 60:2481\u20132489","journal-title":"J Am Coll Cardiol"},{"key":"4641_CR15","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","volume":"385","author":"M Valgimigli","year":"2015","unstructured":"Valgimigli M, Gagnor A, Calabro P et\u00a0al (2015) Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a\u00a0randomised multicentre trial. Lancet 385:2465\u20132476","journal-title":"Lancet"},{"key":"4641_CR16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet J\u2011P et al (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart\u00a0J 37:267\u2013315","journal-title":"Eur Heart J"},{"key":"4641_CR17","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","volume":"380","author":"M Sabate","year":"2012","unstructured":"Sabate M, Cequier A, Iniguez A et al (2012) Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a\u00a0randomised controlled trial. Lancet 380:1482\u20131490","journal-title":"Lancet"},{"key":"4641_CR18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(15)00548-6","volume":"387","author":"M Sabate","year":"2016","unstructured":"Sabate M, Brugaletta S, Cequier A et al (2016) Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5\u2011year results of a\u00a0randomised trial. Lancet 387:357\u2013366","journal-title":"Lancet"},{"key":"4641_CR19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.2012.10065","volume":"308","author":"L Raber","year":"2012","unstructured":"Raber L, Kelbaek H, Ostojic M et al (2012) Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA 308:777\u2013787","journal-title":"JAMA"},{"key":"4641_CR20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","volume":"375","author":"KH Bonaa","year":"2016","unstructured":"Bonaa KH, Mannsverk J, Wiseth R et al (2016) Drug-eluting or bare-metal stents for coronary artery disease. N\u00a0Engl J Med 375:1242\u20131252","journal-title":"N Engl J Med"},{"key":"4641_CR21","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","volume":"372","author":"SS Jolly","year":"2015","unstructured":"Jolly SS, Cairns JA, Yusuf S et\u00a0al (2015) Randomized trial of primary PCI with or without routine manual thrombectomy. N\u00a0Engl J Med 372:1389\u20131398","journal-title":"N Engl J Med"},{"key":"4641_CR22","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","volume":"369","author":"O Fr\u00f6bert","year":"2013","unstructured":"Fr\u00f6bert O, Lagerqvist B, Olivecrona GK et al (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N\u00a0Engl J Med 369:1587\u20131597","journal-title":"N Engl J Med"},{"key":"4641_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ahj.2015.11.006","volume":"172","author":"H Thiele","year":"2016","unstructured":"Thiele H, Desch S, Piek JJ et al (2016) Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: design and rationale of CULPRIT-SHOCK trial. Am Heart\u00a0J 172:160\u2013169","journal-title":"Am Heart J"},{"key":"4641_CR24","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","volume":"376","author":"PC Smits","year":"2017","unstructured":"Smits PC, Abdel-Wahab M, Neumann F\u2011J et al (2017) Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N\u00a0Engl J Med 376:1234\u20131244","journal-title":"N Engl J Med"},{"key":"4641_CR25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","volume":"65","author":"AH Gershlick","year":"2015","unstructured":"Gershlick AH, Khan JN, Kelly DJ et al (2015) Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J\u00a0Am Coll Card 65:963\u2013972","journal-title":"J Am Coll Card"},{"key":"4641_CR26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","volume":"369","author":"DS Wald","year":"2013","unstructured":"Wald DS, Morris JK, Wald NJ et\u00a0al (2013) Randomized trial of preventive angioplasty in myocardial infarction. N\u00a0Engl J Med 369:1115\u20131123","journal-title":"N Engl J Med"},{"key":"4641_CR27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","volume":"386","author":"T Engstrom","year":"2015","unstructured":"Engstrom T, Kelbaek H, Helqvist S et al (2015) Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet 386:665\u2013671","journal-title":"Lancet"},{"key":"4641_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/2048872617719640","author":"S Waha De","year":"2017","unstructured":"De Waha S, Jobs A, P\u00f6ss J et al (2017) Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis. Eur Heart\u00a0J. \n                        https:\/\/doi.org\/10.1177\/2048872617719640","journal-title":"Eur Heart J"},{"key":"4641_CR29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","volume":"382","author":"H Thiele","year":"2013","unstructured":"Thiele H, Zeymer U, Neumann F\u2011J et al (2013) Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock. Final 12-month results of the randomised IntraAortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) Trial. Lancet 382:1638\u20131645","journal-title":"Lancet"},{"key":"4641_CR30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann F\u2011J et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N\u00a0Engl J Med 367:1287\u20131296","journal-title":"N Engl J Med"},{"key":"4641_CR31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1160\/TH16-08-0650","volume":"117","author":"U Zeymer","year":"2017","unstructured":"Zeymer U, Hohlfeld T, Vom Dahl J et\u00a0al (2017) Prospective, randomised trial of the time dependent antiplatelet effects of 500\u202fmg and 250\u202fmg acetylsalicylic acid i.\u202fv. and 300\u202fmg p.\u202fo. in ACS (ACUTE). Thromb Haemost 117:625\u2013635","journal-title":"Thromb Haemost"},{"key":"4641_CR32","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","volume":"371","author":"G Montalescot","year":"2014","unstructured":"Montalescot G, Van \u2019T Hof AW, Lapostolle F et al (2014) Prehospital ticagrelor in ST-segment elevation myocardial infarction. N\u00a0Engl J Med 371:1016\u20131027","journal-title":"N Engl J Med"},{"key":"4641_CR33","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2013.02.036","volume":"61","author":"N Sarafoff","year":"2013","unstructured":"Sarafoff N, Martischnig A, Wealer J et al (2013) Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. J\u00a0Am Coll Cardiol 61:2060\u20132066","journal-title":"J Am Coll Cardiol"},{"key":"4641_CR34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1507854","volume":"373","author":"M Valgimigli","year":"2015","unstructured":"Valgimigli M, Frigoli E, Leonardi S et\u00a0al (2015) Bivalirudin or unfractionated heparin in acute coronary syndromes. N\u00a0Engl J Med 373:997\u20131009","journal-title":"N Engl J Med"},{"key":"4641_CR35","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","volume":"384","author":"A Shahzad","year":"2014","unstructured":"Shahzad A, Kemp I, Mars C et al (2014) Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 384:1849\u20131858","journal-title":"Lancet"},{"key":"4641_CR36","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M et al (2015) Long-term use of ticagrelor in patients with prior myocardial infarction. N\u00a0Engl J Med 372:1791\u20131800","journal-title":"N Engl J Med"},{"key":"4641_CR37","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","volume":"375","author":"CM Gibson","year":"2016","unstructured":"Gibson CM, Mehran R, Bode C et\u00a0al (2016) Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N\u00a0Engl J Med 375:2423\u20132434","journal-title":"N Engl J Med"},{"key":"4641_CR38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"WJ Dewilde","year":"2013","unstructured":"Dewilde WJ, Oirbans T, Verheugt FW et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381:1107\u20131115","journal-title":"Lancet"},{"key":"4641_CR39","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","volume":"63","author":"G Pizarro","year":"2014","unstructured":"Pizarro G, Fern\u00e1ndez-Friera L, Fuster V et al (2014) Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC Trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). J Am Coll Cardiol 63:2356\u20132362","journal-title":"J. Am. Coll. Cardiol."},{"key":"4641_CR40","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"3","author":"B Ibanez","year":"2013","unstructured":"Ibanez B, Macaya C, S\u00e1nchez-Brunete V et al (2013) ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial. Circulation 3:1495\u20131503","journal-title":"Circulation"},{"key":"4641_CR41","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","volume":"67","author":"V Roolvink","year":"2016","unstructured":"Roolvink V, Ib\u00e1\u00f1ez B, Ottervanger JP et al (2016) Early intravenous beta-blockers in patients\u00a0with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. J Am Coll Cardiol 67:2705\u20132715","journal-title":"J. Am. Coll. Cardiol."},{"key":"4641_CR42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/eurheartj\/ehu469","volume":"36","author":"G Niccoli","year":"2015","unstructured":"Niccoli G, Scalone G, Crea F (2015) Acute myocardial infarction with no obstructive coronary atherosclerosis: mechanisms and management. Eur Heart\u00a0J 36:475\u2013481","journal-title":"Eur Heart J"},{"key":"4641_CR43","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","volume":"131","author":"S Pasupathy","year":"2015","unstructured":"Pasupathy S, Air T, Dreyer RP et\u00a0al (2015) Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation 131:861\u2013870","journal-title":"Circulation"},{"key":"4641_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/eurheartj\/ehx504.P4392","volume":"38","author":"S Agewall","year":"2017","unstructured":"Agewall S, Beltrame JF, Reynolds HR et al (2017) ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart\u00a0J 38:143\u2013153","journal-title":"Eur Heart J"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-017-4641-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4641-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4641-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T07:57:19Z","timestamp":1512460639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-017-4641-7"}},"subtitle":["ESC-Leitlinien 2017"],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4641"],"URL":"https:\/\/doi.org\/10.1007\/s00059-017-4641-7","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}